Top news
All coverage
90% efficacy for Pfizer's COVID-19 mRNA vaccine is striking. But we need to wait for the full data
By Harry Al-wassiti, Kylie M. Quinn & Colin W. Pouton
Covid-19 Vaccine Lottery Is a Winning Strategy
By Scott Duke Kominers & Alex Tabarrok
Analysis | No, Pfizer's apparent vaccine success is not a function of Trump's 'Operation Warp Speed'
By Philip Bump
Pfizer says its Covid-19 vaccine, BNT162b2, is 90% effective. What to know, and when it might be available
By Umair Irfan
BioNTech's Covid vaccine: a shot in the arm for Germany's Turkish community
By Philip Oltermann
Pfizer CEO: Our vaccine timing had nothing to do with politics
By Alexis Benveniste
Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine ...
By Giacomo Tognini
Was Pfizer COVID-19 Vaccine Development Funded by Trump Administration?
By Madison Dapcevich
Tracking the vaccine race
By Travis Hartman & Christine Soares
Pfizer's Covid Vaccine, Explained
By Katie Thomas & Carl Zimmer
Pfizer coronavirus vaccine could be cleared by mid-December following release of data showing it is more than 90 ...
By Lena Sun, Carolyn Johnson & Laurie McGinley
Germany funded the development of Pfizer's COVID vaccine—not U.S.'s Operation Warp Speed
By Riley Griffin & Drew Armstrong
Pfizer’s COVID-19 vaccine is 90% effective, preliminary data show
By Erin Garcia de Jesús & Erin Garcia
Trump, without evidence, says Pfizer delayed COVID vaccine results
By Andrew Dunn & Grace Dean
Coronavirus vaccine efficacy compared to shots for other viruses
By Shayanne Gal & Aylin Woodward
Moderna, Pfizer-BioNTech vaccines have been approved in Canada. Here's what you need to know about them
By Amina Zafar & Emily Chung